DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vx4jxl/epicast_report) has announced the addition of GlobalData's new report "EpiCast Report: Osteoporosis - Epidemiology Forecast to 2022" to their offering.
Growing Elderly Populations to Swell Osteoporosis Prevalence in India and China
The climbing elderly populations of India and China will lead to a surge in the number of prevalent cases of osteoporosis in the following decade, predicts the latest report from research and consulting firm The authors.
The company's new epidemiology report forecasts that osteoporosis prevalence in China is set to jump from 50.3 million cases in 2012 to 68.4 million cases in 2022, representing an Annual Growth Rate (AGR) of 3.6%. Similarly, India's prevalent osteoporosis population is expected to climb from 55 million in 2012 to hit 73.8 million a decade later, at an AGR of 3.4%.
According to The authors, the expanding populations of these countries, particularly within the higher age categories, are key contributors to this surge in prevalent cases of osteoporosis - particularly as the age of onset seems to be earlier in these two nations than in many other countries.
To date, osteoporosis has not been recognized as a major health burden in China or India. While disease prevention and treatment have improved over the last two decades, public awareness of osteoporosis remains minimal, particularly in rural areas.
This report provides an overview of the risk factors and global trends of osteoporosis in seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging marketsIndia and China.
This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by The authors's team of industry experts.
Scope
- The Osteoporosis EpiCast Report provide an overview of the risk factors and global trends of osteoporosis in seven major markets (the US, France, Germany, Italy, Spain, the UK, and Japan) in addition to emerging marketsIndia and China.
- It includes a 10-year epidemiological forecast of osteoporosis prevalence segmented by gender and age (40-49, 50-59, 60-69, 70-79, and =80 years).
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Epidemiology
3.1 Risk Factors and Comorbidities
3.1.1 Advanced age and female sex are the leading risk factors for osteoporosis
3.1.2 Low body mass index and physical inactivity can lead to significant bone loss
3.1.3 Previous osteoporotic fracture increases risk of subsequent fracture
3.1.4 Certain diseases and medications increase the risk of osteoporosis
3.1.5 Malnutrition and a nutrient-poor diet decrease BMD
3.1.6 Smoking is an independent risk factor for osteoporosis
3.1.7 Limited daily alcohol consumption may have a protective effect
3.2 Global Trends
3.2.1 The US
3.2.2 Asia
3.3 Forecast Methodology
3.3.1 Sources Used
3.3.2 Forecast Assumptions and Methods
3.3.3 Sources Not Used
3.4 Epidemiology Forecast (2012-2022)
3.4.1 Total Prevalent Cases of Osteoporosis
3.4.2 Age-Specific Prevalent Cases of Osteoporosis
3.4.3 Sex-Specific Total Prevalent Cases of Osteoporosis
3.5 Discussion
3.5.1 The Strength of GlobalData's Epidemiologic Projections
4 Appendix
For more information visit http://www.researchandmarkets.com/research/vx4jxl/epicast_report
Source: GlobalData